Methods
We analyzed 7 patients with drug induced MPRs (group I), 17 patients with viral exanthemas (group II), 6 paients with DRESS [grup III], and 15 healthy children with no history of adverse drug reactions. A complete blood count and immunophenotyping of peripheral blood lymphocytes were carried out, as well serum FasL levels were analyzed in group I-III (Human sFas-L ELISA kit, eBioscience, Vienna, Austria), within 2 days after the onset of the skin eruptions. Tests were repeated between days 3-5 and days 6-10. In group IV, these analyses were performed once. Liver and renal functions were also eveluated in group I-III. Serum immunoglobulin levels were analyzed in group 3. Skin tests with the suspected drug were applied in cases in group I and III according to the guidelines. In group II, skin tests, drug provocation tests, and viral serology were performed if needed.
Results
Absolute numbers of peripheral blood lymphocytes ans sFasL levels in initial samples of cases in 4 groups are summarized in Table 1 .
Trakya University, Turkey B cell counts were low in group III when compared to group I and IV. CD4+cells, CD19+cells and NK cells were low in group III when compared to group II. There were no significant differences in sFasL levels between the groups.
Conclusions
In our study, sFasL levels were not found to be useful to discriminate viral exanthemas from drug rashes. Additionally, the results were not found to be different on repeated evaluations. The only significant difference between drug induced MPRs and DRESS was B cell counts. The low numbers of B cells in DRESS within the first 2 days of the symptoms might be a useful predictor of DRESS development. 
